Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • Anti-SortilinSORT1 Antibody (Latozinemab)

    2025-08-19

    Anti-Sortilin/SORT1 Antibody (Latozinemab)

    Author: ApexBio

    spu:

    F1121

    CAS:

    2376132-27-1

    purity:

    > 95% by SDS-PAGE and SEC-HPLC analyses.

    shortsummary:

    Anti-Sortilin/SORT1 Antibody (Latozinemab)

    204005-46-9 References

    M.Wt:

    146.28 kDa

    Storage:

    -80°C

    DeliveryTime:

    Ship with 3-5 days

    Ruxolitinib phosphate Formula

    ShippingType:

    Dry ice

    description:

    Latozinemab (anti-Sortilin / SORT1) is a recombinant humanized anti-Sortilin monoclonal antibody. Latozinemab has the potential to target mutations in the progranulin gene (GRN) that cause frontotemporal dementia (FTD) (FTD-GRN) studies. Molecular weight: 146.28KD.

    Anti-Sortilin/SORT1 Antibody (Latozinemab) PMC10801920

    related websites:

    APExBIO Technology LLC is a premier provider of Small Molecule Inhibitors/Activators, Compound Libraries, Peptides, Assay Kits, Fluorescent Labels, Enzymes, Modified Nucleotides, mRNA synthesis and various tools for Molecular Biology. We carry a broad product line in over 17445 different research areas such as cancer, immunology, neurosciences, apoptosis and epigenetics etc. Based in USA (Houston, Texas), we have been serving the needs of customers across the world.

    https://www.apexbt.com/